A controlled trial of intratumoral ONYX‐015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. - Khuri,F.R.; Nemunaitis,J.; Ganly,I.; Arseneau,J.; Tannock,I.F.; Romel,L.; Gore,M.; Ironside,J.; MacDougall,R.H.; Heise,C.; Randlev,B.; Gillenwater,A.M.; et al. (Nat Med, 2000)